EndoGastric Solutions Stock
EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.
Sign up today and learn more about EndoGastric Solutions Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About EndoGastric Solutions Stock
EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure—a minimally invasive solution that addresses a significant unmet clinical need. EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.
Funding History
| June 2003 | $5.0M |
|---|---|
| September 2004 | $12.0M |
| February 2006 | $32.0M |
| August 2007 | $30.0M |
| June 2009 | $3.8M |
| July 2009 | $7.5M |
| October 2009 | $9.5M |
| November 2009 | $21.5M |
| August 2010 | $30.0M |
| March 2012 | $10.9M |
| April 2012 | $2.1M |
| June 2012 | $13.0M |
| February 2013 | $10.0M |
| April 2014 | $1.0M |
| May 2014 | $30.0M |
| April 2015 | $1.3M |
| May 2015 | $10.0M |
| December 2015 | $50.0M |
| June 2018 | $40.6M |
| May 2019 | $15.0M |
| December 2020 | $27.0M |
Management
President & CEO
Skip Baldino
Corporate Compliance Officer
Steve Hoffman
Vice President, Marketing and Professional Education
Ted Stephens
Vice President, R&D, Operations
Darren Crow
Chief Financial Officer
Michael Burke
Vice President of Human Asset Development.
Patrick Crilly
PhD Vice President, Healthcare Economics, Policy and Reimbursement
Philip Macdonald
VP of Marketing
Josh DeFonzo
Board Member
Kathleen Regan
Principal
Kunal Paymaster
Board Member
Brent Ahrens
Board of Directors
Jordan S. Davis
Board Member
Mike Carusi
Investor
Mike Carusi
Board of Directors
Uri Geiger
Member of the Board of Directors
Floyd Loop
Board of Directors
Arda Minocherhomjee
Chief Medical Officer - Medical Doctor - Surgeon
Adrian Lobontiu
Medical Director
Adrian Lobontiu
Board Member
Alejandro Sanchez
Medical Advisory Board
Reginald Bell
Medical Advisory Board
John Hunter
Board Member
Guy Jordan
Medical Advisory Board
Blair Jobe
Vice President, Sales
Martin Reid
Member of the Board of Directors
Joe Mandato
Board of Directors
Lee Wrubel
Press
bnnbreaking - Mar, 1 2024
Gastroesophageal Reflux Disease (GERD) Device Market: A Rapidly Growing Sectorfinance - Dec, 19 2023
Aquyre Biosciences Announces Appointment of Gregory ...marketresearchblog - Dec, 19 2023
Gastroesophageal Reflux Disease (GERD) Devices Market is ...pharmiweb - Dec, 19 2023
Global Gastroesophageal Reflux Disease (GERD) Devices ...EquityZen Recognized As:
